TD Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-41,117
Closed -$748K 1524
2021
Q4
$748K Hold
41,117
﹤0.01% 1328
2021
Q3
$804K Hold
41,117
﹤0.01% 1304
2021
Q2
$1.87M Buy
41,117
+7,106
+21% +$329K ﹤0.01% 1117
2021
Q1
$1.71M Buy
34,011
+15,388
+83% +$1.05M ﹤0.01% 1143
2020
Q4
$1.67M Buy
18,623
+800
+4% +$67.3K ﹤0.01% 1075
2020
Q3
$1.36M Buy
+17,823
New +$1.13M ﹤0.01% 1008

Other funds holding CELL

TD Asset Management's CELL Position: Q1 2022 in Review

TD Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 41,117 shares — an estimated $748K sold.

TD Asset Management first reported a position in CELL in Q3 2020 and held it in 6 quarters. The position peaked at $1.87M in Q2 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • TD Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • TD Asset Management sold 41,117 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $748K.
  • TD Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • TD Asset Management's PhenomeX Inc. Common Stock position peaked at $1.87M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.